Fenretinide ameliorates insulin resistance and fatty liver in obese mice

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 3, 2012, Pages 369-375

  Koh, In Uk ^a,b   Jun, Hye Seung ^a   Choi, Joo Sun ^a   Lim, Joo Hyun ^a   Kim, Won Ho ^a   Yoon, Jong Bok ^b   Song, Jihyun ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Yonsei University   (South Korea)

Author keywords

Fatty acid oxidation; Fatty liver; Fenretinide; Insulin resistance; Retinol binding protein 4

Indexed keywords

ACYL COENZYME A OXIDASE; ADIPONECTIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; FATTY ACID; FENRETINIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREALBUMIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FATTY ACID BLOOD LEVEL; FATTY LIVER; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LIPID OXIDATION; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIET, HIGH-FAT; FATTY LIVER; FENRETINIDE; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PREALBUMIN; RETINOL-BINDING PROTEINS, PLASMA; WEIGHT GAIN;

EID: 84863286916     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.369     Document Type: Article

References (21)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844-1850 (2001).
2. Deivanayagam S, Mohammed BS, Vitola BE, Naguib GH, Keshen TH, Kirk EP, Klein S. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am. J. Clin. Nutr., 88, 257-262 (2008).
3. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol., 316, 129-139 (2010).
4. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol. (Oxf.), 186, 5-16 (2006).
5. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol. Med., 14, 741-751 (2008).
6. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, Blaner WS. Retinoids and retinoid-binding protein expression in rat adipocytes. J. Biol. Chem., 267, 1805-1810 (1992).
7. Mody N, Graham TE, Tsuji Y, Yang Q, Kahn BB. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am. J. Physiol. Endocrinol. Metab., 294, E785-E793 (2008).
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436, 356-362 (2005).
9. Lewis JG, Shand BI, Elder PA, Scott RS. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance. Diabetes Res. Clin. Pract., 80, e13-e15 (2008).
10. von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B, Humpert PM. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia, 50, 1930-1937 (2007).
11. Preitner F, Mody N, Graham TE, Peroni OD, Kahn BB. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab., 297, E1420-E1429 (2009).
12. Johansson H, Gandini S, Guerrieri-Gonzaga A, Iodice S, Ruscica M, Bonanni B, Gulisano M, Magni P, Formelli F, Decensi A. Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer Res., 68, 9512-9518 (2008).
13. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT, Brown CC, Sporn MBN. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39, 1339-1346 (1979).
14. Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M, Andreoli C, Del Vecchio M, Formelli F, Barbieri A. Tolerability of the synthetic retinoid fenretinide (HPR). Eur. J. Cancer Clin. Oncol., 25, 805-808 (1989).
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419 (1985).
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem., 226, 497-509 (1957).
17. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol., 94, 2467-2474 (1999).
18. Motani A, Wang Z, Conn M, Siegler K, Zhang Y, Liu Q, Johnstone S, Xu H, Thibault S, Wang Y, Fan P, Connors R, Le H, Xu G, Walker N, Shan B, Coward P. Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivo. J. Biol. Chem., 284, 7673-7680 (2009).
19. Cooper JP, Hwang K, Singh H, Wang D, Reynolds CP, Curley RW Jr., Williams SC, Maurer BJ, Kang MH. Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure. Br. J. Pharmacol., 163, 1263-1275 (2011).
20. Lee YM, Choi JS, Kim MH, Jung MH, Lee YS, Song J. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition, 22, 956-964 (2006).
21. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792 (2006).